Seoul, South Korea

Jinwoo Chung

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jinwoo Chung: Innovator in Fibrosis Treatment and Mobile Technology

Introduction

Jinwoo Chung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of medical treatment and mobile technology. With a total of 3 patents, his work reflects a commitment to innovation and improvement in these areas.

Latest Patents

One of Jinwoo Chung's latest patents is focused on "Compositions and methods for treating or preventing fibrosis." This application relates to compositions and methods comprising polypeptides derived from MFG-E8 for treating and preventing fibrosis and other diseases. Another notable patent is the "Method of controlling instant message and mobile terminal using the same." This invention provides a method and apparatus for controlling instant messages, which includes a mobile terminal receiving a message, searching a telephone directory for sender information, and displaying the text contents of the instant message on the idle screen of the mobile terminal for a specific duration of time that is controllable by the user.

Career Highlights

Jinwoo Chung has worked with notable companies such as LG Electronics Inc. and Nexel Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in technology and healthcare.

Collaborations

Some of his coworkers include Chiwon Song and Jiyoun Lee, who have collaborated with him on various projects, enhancing the scope and impact of his inventions.

Conclusion

Jinwoo Chung's contributions to the fields of fibrosis treatment and mobile technology demonstrate his innovative spirit and dedication to improving lives through his inventions. His work continues to inspire future advancements in these critical areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…